Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds
HL Ang, CD Mohan, MK Shanmugam… - Medicinal research …, 2023 - Wiley Online Library
Epithelial‐mesenchymal transition (EMT) is a complex process with a primordial role in
cellular transformation whereby an epithelial cell transforms and acquires a mesenchymal …
cellular transformation whereby an epithelial cell transforms and acquires a mesenchymal …
The long and short non-coding RNAs modulating EZH2 signaling in cancer
Non-coding RNAs (ncRNAs) are a large family of RNA molecules with no capability in
encoding proteins. However, they participate in developmental and biological processes …
encoding proteins. However, they participate in developmental and biological processes …
The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges
Epithelial-to-Mesenchymal Transition (EMT) has been shown to be crucial in tumorigenesis
where the EMT program enhances metastasis, chemoresistance and tumor stemness. Due …
where the EMT program enhances metastasis, chemoresistance and tumor stemness. Due …
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
Y **ang, Z Guo, P Zhu, J Chen, Y Huang - Cancer medicine, 2019 - Wiley Online Library
Traditional Chinese medicine (TCM) has been practiced for thousands of years and at the
present time is widely accepted as an alternative treatment for cancer. In this review, we …
present time is widely accepted as an alternative treatment for cancer. In this review, we …
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Numerous natural products originated from Chinese herbal medicine exhibit anti-cancer
activities, including anti-proliferative, pro-apoptotic, anti-metastatic, anti-angiogenic effects …
activities, including anti-proliferative, pro-apoptotic, anti-metastatic, anti-angiogenic effects …
The role of polyphenols in overcoming cancer drug resistance: A comprehensive review
P Maleki Dana, F Sadoughi, Z Asemi… - Cellular & molecular …, 2022 - Springer
Chemotherapeutic drugs are used to treat advanced stages of cancer or following surgery.
However, cancers often develop resistance against drugs, leading to failure of treatment and …
However, cancers often develop resistance against drugs, leading to failure of treatment and …
The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic …
Pancreatic ductal adenocarcinoma (PDAC) is one of the lethal malignancies with the lowest
median and overall survival rate among all human malignancies. The major problems with …
median and overall survival rate among all human malignancies. The major problems with …
Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases
The long non-coding RNAs (lncRNAs) are the crucial regulators of human chronic diseases.
Therefore, approaches such as antisense oligonucleotides, RNAi technology, and small …
Therefore, approaches such as antisense oligonucleotides, RNAi technology, and small …
Combinatorial epigenetics impact of polyphenols and phytochemicals in cancer prevention and therapy
I Arora, M Sharma, TO Tollefsbol - International journal of molecular …, 2019 - mdpi.com
Polyphenols are potent micronutrients that can be found in large quantities in various food
sources and spices. These compounds, also known as phenolics due to their phenolic …
sources and spices. These compounds, also known as phenolics due to their phenolic …
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
W **e, M Chu, G Song, Z Zuo, Z Han, C Chen… - Seminars in cancer …, 2022 - Elsevier
Pancreatic cancer is one of the most common causes of cancer death in the world due to the
lack of early symptoms, metastasis occurrence and chemoresistance. Therefore, early …
lack of early symptoms, metastasis occurrence and chemoresistance. Therefore, early …